ASND Competitors & Alternatives
Compare Ascendis Pharma AS with similar stocks in the same industry
Biotechnology
ASND
Main Stock$227.31
Tradestie Score
69
Market Cap
$12.36B
P/E Ratio
17.8
Revenue Growth
1.1%
Analyst Upside
+36.2%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GMAB
Genmab A/S ADS
|
$34.55
|
$19.56B | 28.2 | 42 | Compare |
|
INCY
Incyte Genomics Inc
|
$117.14
|
$16.93B | 15.9 | 55 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.63
|
$15.70B | 31.3 | 66 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$16.69
|
$15.22B | - | 49 | Compare |
|
EXEL
Exelixis Inc
|
$57.94
|
$11.09B | 18.4 | 48 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$35.50
|
$10.76B | - | 50 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$188.94
|
$10.74B | - | 36 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$58.44
|
$10.53B | 166.3 | 59 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$44.00
|
$10.49B | - | 68 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$66.91
|
$10.22B | - | 73 | Compare |
More ASND Analysis
Data updated: Oct 01, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry